Blood Lipid Responses to Diets Enriched with Cottonseed Oil Compared With Olive Oil in Adults with High Cholesterol in a Randomized Trial

M Catherine Prater, Alexis R Scheurell, Chad M Paton, Jamie A Cooper, M Catherine Prater, Alexis R Scheurell, Chad M Paton, Jamie A Cooper

Abstract

Background: Increasing unsaturated fat intake is beneficial for cardiovascular health, but the type of unsaturated fat to recommend remains equivocal.

Objectives: We investigated the effects of an 8-week diet intervention that was rich in either cottonseed oil (CSO; PUFA rich) or olive oil (OO; MUFA rich) on blood lipids in hypercholesterolemic adults.

Methods: Forty-three men and women with hypercholesterolemia (53 ± 10 years; BMI, 27.6 ± 4.8 kg/m2) completed this randomized parallel clinical trial consisting of an 8-week partial outpatient feeding intervention. Participants were given meals and snacks accounting for ∼60% of their daily energy needs, with 30% of energy needs from either CSO (n = 21) or OO (n = 22). At pre- and postdiet intervention visits, participants consumed a high-SFA meal (35% of total energy needs; 70% of energy from fat). The primary outcomes of fasting cholesterol profiles and secondary outcomes of postprandial blood lipids and glycemic markers were assessed over a 5-hour period.

Results: There were greater reductions from baseline to week 8 in fasting serum total cholesterol (TC; -17.0 ± 3.94 mg/dL compared with -2.18 ± 3.72 mg/dL, respectively; P = 0.008), LDL cholesterol (-19.7 ± 3.94 mg/dL compared with -5.72 ± 4.23 mg/dL, respectively; P = 0.018), non-HDL cholesterol (-20.8 mg/dL ± 4.00 compared with -6.61 ± 4.01 mg/dL, respectively; P = 0.014), and apoB (-11.8 mg/dL ± 2.37 compared with -3.10 ± 2.99 mg/dL, respectively; P = 0.05), in CSO compared with OO. There were also visit effects from baseline to week 8 for increases in HDL cholesterol (CSO, 56.5 ± 2.79 mg/dL to 60.2 ± 3.35 mg/dL, respectively; OO: 59.7 ± 2.63 mg/dL to 64.1 ± 2.24 mg/dL, respectively; P < 0.001), and decreases in the TC:HDL-cholesterol ratio (CSO, 4.30 ± 0.27 mg/dL to 3.78 ± 0.27 mg/dL, respectively; OO, 3.94 ± 0.16 mg/dL to 3.57 ± 0.11 mg/dL, respectively; P < 0.001), regardless of group assignment. In response to the high-SFA meal, there were differences in postprandial plasma glucose (P = 0.003) and triglyceride (P = 0.004) responses and a trend in nonesterified fatty acids (P = 0.11) between groups, showing protection in the postprandial state from an occasional high-SFA fat meal with CSO, but not OO, diet enrichment.

Conclusions: CSO, but not OO, diet enrichment caused substantial improvements in fasting and postprandial blood lipids and postprandial glycemia in hypercholesterolemic adults. This trial was registered at clinicaltrials.gov as NCT04397055.

Keywords: HDL cholesterol; LDL cholesterol; SCD1; cottonseed oil; high-fat diet; hypercholesterolemia; olive oil; stearoyl-CoA desaturase-1.

© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Figures

FIGURE 1
FIGURE 1
CONSORT flow diagram selection of participants.
FIGURE 2
FIGURE 2
Serum fasting (A) TC, (B) LDL cholesterol, (C) apoB, (D) non–HDL cholesterol, (E) TC:HDL-cholesterol ratio, and (F) HDL cholesterol from pre-, mid-, and postdiet intervention visits in adults with hypercholesterolemia (CSO, n = 21; OO, n = 22). Data were analyzed using a 2-way (treatment × visit) repeated-measures ANOVA. *Significant treatment × visit interaction (P < 0.001) and a difference from baseline at a P value < 0.05. ǂA trend for a treatment × visit interaction (P = 0.09) and a difference from baseline at a P value < 0.01. #Significant visit effect and a difference from baseline, regardless of group assignment, at a P value < 0.05. All values are presented as means ± SEMs. Preintervention visits were at week 0, midintervention visits at week 4, and postintervention visits at week 8. CSO, cottonseed oil; Mid, midintervention; OO, olive oil; Pre, preintervention; Post, postintervention; TC, total cholesterol.
FIGURE 3
FIGURE 3
Fasting biochemical markers of (A) plasma triglycerides, (B) plasma NEFAs, (C) serum LDL-P, (D) serum LDL medium, (E) plasma insulin, (F) plasma glucose, (G) serum HDL large, and (H) serum LDL small, from pre-, mid-, and postdiet intervention visits in adults with hypercholesterolemia (CSO, n = 21; OO, n = 22). Data were analyzed using a 2-way (treatment × visit) repeated-measures ANOVA. #Significant visit effect and a difference from baseline, regardless of group assignment, at a P value < 0.05. All values are presented as means ± SEMs. Preintervention visits were at week 0, midintervention visits at week 4, and postintervention visits at week 8. LDL-P, LDL particle number; Mid, midintervention; NEFA, nonesterified fatty acid; Pre, preintervention; Post, postintervention.
FIGURE 4
FIGURE 4
Time course for (A, B) plasma TGs, (C, D) NEFAs, (E, F) insulin, and (G, H) glucose for each treatment at pre- and postintervention visits in adults with hypercholesterolemia (CSO, n = 21; OO, n = 21). Participants consumed a high–saturated fat breakfast meal immediately after time 0. *Significant treatment × visit interaction and a difference between the pre- and postintervention meal responses within a group (P < 0.05). ǂTrend for treatment × visit interaction and a difference between the pre- and postintervention meal responses within a group (P = 0.10). All values are presented as means ± SEMs. Preintervention visits were at week 0 and postintervention visits were at week 8. CSO, cottonseed oil; NEFA, nonesterified fatty acid; OO, olive oil; Post, postintervention; Pre, preintervention; TG, triglyceride.

References

    1. WHO . Cardiovascular diseases (CVDs) [Internet]. Geneva, Switzerland: WHO; 2021. Available from: .
    1. Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med. 2017;167(11):ITC81–96.
    1. Carroll MD, Fryar CD. Total and high-density lipoprotein cholesterol in adults: United States, 2015–2018. NCHS Data Brief, no 363. Hyattsville, MD: National Center for Health Statistics. 2020.
    1. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fatty acids and risk of coronary heart disease: Modulation by replacement nutrients. Curr Atheroscler Rep. 2010;12(6):384–90.
    1. Mensink RP, Effects of saturated fatty acids on serum lipids and lipoproteins: A systematic review and regression analysis. Geneva, Switzerland: World Health Organization; 2016.
    1. Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020;5(5):CD011737.
    1. Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: A systematic review and meta-analysis of cohort studies. Lipids Health Dis. 2014;13(1):154.
    1. Ghobadi S, Hassanzadeh-Rostami Z, Mohammadian F, Nikfetrat A, Ghasemifard N, Raeisi Dehkordi H, Faghih S. Comparison of blood lipid-lowering effects of olive oil and other plant oils: A systematic review and meta-analysis of 27 randomized placebo-controlled clinical trials. Crit Rev Food Sci Nutr. 2019;59(13):2110–24.
    1. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci. 2004;41(1):41–78.
    1. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Nutr Rev. 2004;62(9):333–9.
    1. Polley KR, Oswell NJ, Pegg RB, Paton CM, Cooper JA. A 5-day high-fat diet rich in cottonseed oil improves cholesterol profiles and triglycerides compared to olive oil in healthy men. Nutr Res. 2018;60:43–53.
    1. Davis KE, Prasad C, Imrhan V. Consumption of a diet rich in cottonseed oil (CSO) lowers total and LDL cholesterol in normo-cholesterolemic subjects. Nutrients. 2012;4(7):602–10.
    1. Paton CM, Vaughan RA, Alpergin ESS, Assadi-Porter F, Dowd MK. Dihydrosterculic acid from cottonseed oil suppresses desaturase activity and improves liver metabolomic profiles of high-fat–fed mice. Nutr Res. 2017;45:52–62.
    1. Alves AQ, da Silva Jr VA, Góes AJS, Silva MS, de Oliveira GG, Bastos I, de Castro Neto AG, Alves AJ. The fatty acid composition of vegetable oils and their potential use in wound care. Adv Skin Wound Care. 2019;32:1–8.
    1. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92(5):1189–96.
    1. International Olive Council . Olive oil production and consumption up by 1 million tonnes in the last 25 years. IOC News; Verona, Italy: 2018. .
    1. Lombardi A, Carlucci D, Cavallo C, De Gennaro B, Del Giudice T, Giannoccaro G, Paparella A, Roselli L, Vecchio R, Cicia G. Do consumers understand health claims on extra-virgin olive oil?. Food Res Int. 2021;143:110267.
    1. Pichierri M, Peluso AM, Pino G, Guido G. Health claims’ text clarity, perceived healthiness of extra-virgin olive oil, and arousal: An experiment using facereader. Trends Food Sci Technol. 2021;116:1186–94.
    1. Mayo Clinic Staff. High cholesterol: Diagnosis [Internet]. Clinic MayoMayo Foundation for Medical Education and Research; 2021. .
    1. National Institutes of Health: National Heart, Lung and Blood Institute . Cholesterol levels: What you need to know. NIH MedlinePlus [Internet]. Bethesda, MD: 2020; .
    1. Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis. 2008;196(2):696–703.
    1. Jeong SM, Choi S, Kim K, Kim SM, Lee G, Park SY, Kim YY, Son JS, Yun JM, Park SM. Effect of change in total cholesterol levels on cardiovascular disease among young adults. J Am Heart Assoc. 2018;7(12):e008819.
    1. Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): Validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995;56(4):423–32.
    1. Cooper JA, Watras AC, O'Brien MJ, Luke A, Dobratz JR, Earthman CP, Schoeller DA. Assessing validity and reliability of resting metabolic rate in six gas analysis systems. J Am Diet Assoc. 2009;109(1):128–32.
    1. Stevenson JL, Miller MK, Skillman HE, Paton CM, Cooper JA. A PUFA-rich diet improves fat oxidation following saturated fat-rich meal. Eur J Nutr. 2017;56(5):1845–57.
    1. JB Weir. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949;109:1–9.
    1. Trumbo P, Schlicker S, Yates A, Poos M, Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. J AM Diet Assoc. 2002;102(11):1621–30.
    1. Gersovitz M, Madden JP, Smiciklas-Wright H. Validity of the 24-hr. dietary recall and seven-day record for group comparisons. J Am Diet Assoc. 1978;73(1):48–55.
    1. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96.
    1. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire short form (IPAQ-SF): A systematic review. Int J Behav Nutr Phys Act. 2011;8(1):115.
    1. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R, Participants SW. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clinic Proceedings;. Elsevier: 2003:965–78.
    1. McRorie JW Jr. Evidence-based approach to fiber supplements and clinically meaningful health benefits, part 1: What to look for and how to recommend an effective fiber therapy. Nutr Today. 2015;50(2):82.
    1. Schmitz G, Langmann T. Pharmacogenomics of cholesterol-lowering therapy. Vasc Pharmacol. 2006;44(2):75–89.
    1. Oni-Orisan A, Hoffmann TJ, Ranatunga D, Medina MW, Jorgenson E, Schaefer C, Krauss RM, Iribarren C, Risch N. Characterization of statin low-density lipoprotein cholesterol dose-response using electronic health records in a large population-based cohort. Circ Genom Precis Med. 2018;11:e002043.
    1. Shapiro MD, Fazio S. Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease. F1000Res. 2017;6:134.
    1. Carr SS, Hooper AJ, Sullivan DR, Burnett JR. Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment. Pathology. 2019;51(2):148–54.
    1. Robinson JG, Wang S, Jacobson TA. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Am J Cardiol. 2012;110(10):1468–76.
    1. U.S. Department of Agriculture and U.S. Department of Halth and Human Services. Dietary guidelines for Americans, 2020–2025. 9th ed. 2020. Washington D.C.Available at.
    1. Schwingshackl L, Bogensberger B, Benčič A, Knüppel S, Boeing H, Hoffmann G. Effects of oils and solid fats on blood lipids: A systematic review and network meta-analysis. J Lipid Res. 2018;59(9):1771–82.
    1. Sun Y, Neelakantan N, Wu Y, Lote-Oke R, Pan A, van Dam RM. Palm oil consumption increases LDL cholesterol compared with vegetable oils low in saturated fat in a meta-analysis of clinical trials. J Nutr. 2015;145(7):1549–58.
    1. Vafeiadou K, Weech M, Altowaijri H, Todd S, Yaqoob P, Jackson KG, Lovegrove JA. Replacement of saturated with unsaturated fats had no impact on vascular function but beneficial effects on lipid biomarkers, E-selectin, and blood pressure: Results from the randomized, controlled Dietary Intervention and Vascular Function (DIVAS) study. Am J Clin Nutr. 2015;102(1):40–8.
    1. Baum SJ, Kris-Etherton PM, Willett WC, Lichtenstein AH, Rudel LL, Maki KC, Whelan J, Ramsden CE, Block RC. Fatty acids in cardiovascular health and disease: A comprehensive update. J Clin Lipidol. 2012;6(3):216–34.
    1. Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids. 2010;45(10):893–905.
    1. Abdelhamid AS, Martin N, Bridges C, Brainard JS, Wang X, Brown TJ, Hanson S, Jimoh OF, Ajabnoor SM, Deane KH. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;7(7):CD012345.
    1. Maki K, Lawless A, Kelley K, Kaden V, Geiger C, Palacios O, Dicklin M. Corn oil intake favorably impacts lipoprotein cholesterol, apolipoprotein and lipoprotein particle levels compared with extra-virgin olive oil. Eur J Clin Nutr. 2017;71(1):33–8.
    1. Wagner K-H, Tomasch R, Elmadfa I. Impact of diets containing corn oil or olive/sunflower oil mixture on the human plasma and lipoprotein lipid metabolism. Eur J Nutr. 2001;40(4):161–7.
    1. Utarwuthipong T, Komindr S, Pakpeankitvatana V, Songchitsomboon S, Thongmuang N. Small dense low-density lipoprotein concentration and oxidative susceptibility changes after consumption of soybean oil, rice bran oil, palm oil and mixed rice bran/palm oil in hypercholesterolaemic women. J Int Med Res. 2009;37(1):96–104.
    1. Binkoski AE, Kris-Etherton PM, Wilson TA, Mountain ML, Nicolosi RJ. Balance of unsaturated fatty acids is important to a cholesterol-lowering diet: Comparison of mid-oleic sunflower oil and olive oil on cardiovascular disease risk factors. J Am Diet Assoc. 2005;105(7):1080–6.
    1. Baer DJ, Henderson T, Gebauer SK. Consumption of high-oleic soybean oil improves lipid and lipoprotein profile in humans compared to a palm oil blend: A randomized controlled trial. Lipids. 2021;56(3):313–25.
    1. Hampden KA. Rober EF, Stewart G. Effects of feeding whole kernel cottonseed on growth, reproduction and biochemical parameters. Fed. Proc. 1984;42:1323.
    1. Edwards M, Radcliffe J. A comparison of the effect of cottonseed oil and corn oil on lipid status in the rat. Biochem Arch. 1995;11:103–9.
    1. Radcliffe J, King C, Czajka-Narins D, Imrhan V. Serum and liver lipids in rats fed diets containing corn oil, cottonseed oil, or a mixture of corn and cottonseed oils. Plant Foods Hum Nutr. 2001;56(1):51–60.
    1. Radcliffe J, Czajka-Narins D, Imrhan V. Fatty acid composition of serum, adipose tissue, and liver in rats fed diets containing corn oil or cottonseed oil. Plant Foods Hum Nutr. 2004;59(2):73–7.
    1. Radcliffe J, Czajka-Narins D. Lipids and tocopherols in serum and liver of female rats fed diets containing corn oil or cottonseed oil. Plant Foods Hum Nutr. 2006;61(1):33–6.
    1. Yang A, Qi M, Wang X, Wang S, Sun L, Qi D, Zhu L, Duan Y, Gao X, Rajput SAet al. . Refined cottonseed oil as a replacement for soybean oil in broiler diet. Food Sci Nutr. 2019;7:1027–34.
    1. Paton CM, Ntambi JM. Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab. 2009;297(1):E28–37.
    1. Gutfinger T, Letan A. Studies of unsaponifiables in several vegetable oils. Lipids. 1974;9(9):658–63.
    1. Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, Ooi TC, Perez-Martinez P, Bilianou H, Anagnostopoulou K, Panotopoulos G. Assessment and clinical relevance of non-fasting and postprandial triglycerides: An expert panel statement. Curr Vasc Pharmacol. 2011;9:258–70.
    1. Kolovou GD, Watts GF, Mikhailidis DP, Pérez-Martínez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-Miranda J. Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profiles: Executive summary of a 2019 expert panel statement. Curr Vasc Pharmacol. 2019;17(5):538–40.
    1. Jelic K, Hallgreen CE, Colding-Jørgensen M. A model of NEFA dynamics with focus on the postprandial state. Ann Biomed Eng. 2009;37(9):1897–909.
    1. Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol. 2012;13(6):383–96.
    1. Gomez-Delgado F, Alcala-Diaz JF, Leon-Acuña A, Lopez-Moreno J, Delgado-Lista J, Gomez-Marin B, Roncero-Ramos I, Yubero-Serrano EM, Rangel-Zuñiga OA, Vals-Delgado C. Apolipoprotein E genetic variants interact with Mediterranean diet to modulate postprandial hypertriglyceridemia in coronary heart disease patients: CORDIOPREV study. Eur J Clin Invest. 2019;49(8):e13146.
    1. Gomez-Marin B, Gomez-Delgado F, Lopez-Moreno J, Alcala-Diaz JF, Jimenez-Lucena R, Torres-Peña JD, Garcia-Rios A, Ortiz-Morales AM, Yubero-Serrano EM, Del Mar Malagon Met al. . Long-term consumption of a Mediterranean diet improves postprandial lipemia in patients with type 2 diabetes: The Cordioprev randomized trial. Am J Clin Nutr. 2018;108(5):963–70.

Source: PubMed

3
Subscribe